Cargando…

A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol

Aggregation and spreading of α-Synuclein (αSyn) are hallmarks of several neurodegenerative diseases, thus monitoring human αSyn (hαSyn) in animal models or cell cultures is vital for the field. However, the detection of native hαSyn in such systems is challenging. We show that the nanobody NbSyn87,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerdes, Christoph, Waal, Natalia, Offner, Thomas, Fornasiero, Eugenio F., Wender, Nora, Verbarg, Hannes, Manzini, Ivan, Trenkwalder, Claudia, Mollenhauer, Brit, Strohäker, Timo, Zweckstetter, Markus, Becker, Stefan, Rizzoli, Silvio O., Basmanav, Fitnat Buket, Opazo, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264335/ https://www.ncbi.nlm.nih.gov/pubmed/32483166 http://dx.doi.org/10.1038/s41467-020-16575-0

Ejemplares similares

Nanobodies reveal an extra-synaptic population of SNAP-25 and Syntaxin 1A in hippocampal neurons
por: Maidorn, Manuel, et al.
Publicado: (2018)

Chicago sky blue 6B inhibits α-synuclein aggregation and propagation
por: Min, Joo-Ok, et al.
Publicado: (2022)

Interplay between tau and α‐synuclein liquid–liquid phase separation
por: Siegert, Anna, et al.
Publicado: (2021)

The Molecular Basis of the Interaction of Cyclophilin A with α‐Synuclein
por: Favretto, Filippo, et al.
Publicado: (2020)

GFP nanobodies reveal recently-exocytosed pHluorin molecules
por: Seitz, Katharina J., et al.
Publicado: (2019)

Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein
por: Frieg, Benedikt, et al.
Publicado: (2022)

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
por: Mollenhauer, Brit, et al.
Publicado: (2012)

Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
por: Lázaro, Diana F., et al.
Publicado: (2014)

α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
por: Butler, Yemima R., et al.
Publicado: (2022)

The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease
por: Halsband, Claire, et al.
Publicado: (2018)

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein
por: Barkovits, Katalin, et al.
Publicado: (2020)

Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts
por: Strohäker, Timo, et al.
Publicado: (2019)

Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells
por: Moree, Ben, et al.
Publicado: (2015)

Pathological changes are associated with shifts in the employment of synonymous codons at the transcriptome level
por: Fornasiero, Eugenio F., et al.
Publicado: (2019)

Studying Synaptic Vesicle Pools using Photoconversion of Styryl Dyes
por: Opazo, Felipe, et al.
Publicado: (2010)

Gold-Conjugated Nanobodies for Targeted Imaging Using High-Resolution Secondary Ion Mass Spectrometry
por: Agüi-Gonzalez, Paola, et al.
Publicado: (2021)

Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease
por: Zimansky, Larissa, et al.
Publicado: (2021)

Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ
por: Butler, David C., et al.
Publicado: (2016)

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
por: Abdi, Ilham Y., et al.
Publicado: (2021)

α-Synuclein in the Synaptic Vesicle Liquid Phase: Active Player or Passive Bystander?
por: Brodin, Lennart, et al.
Publicado: (2022)

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
por: Poggiolini, Ilaria, et al.
Publicado: (2021)

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
por: Stuendl, Anne, et al.
Publicado: (2016)

Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuIC
por: Ruf, Viktoria C., et al.
Publicado: (2020)

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
por: Oliveira, Luis M. A., et al.
Publicado: (2021)

Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
por: Bibl, Mirko, et al.
Publicado: (2010)

Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
por: Zhang, Shuyu, et al.
Publicado: (2023)

Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation
por: Kunadt, Marcel, et al.
Publicado: (2015)

Trafficking proteins show limited differences in mobility across different postsynaptic spines
por: Mougios, Nikolaos, et al.
Publicado: (2023)

Status of Current Biofluid Biomarkers in Parkinson's Disease
por: Mollenhauer, Brit
Publicado: (2023)

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
por: Chatterjee, Diptaman, et al.
Publicado: (2018)

Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species
por: Iljina, Marija, et al.
Publicado: (2017)

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid(42) and DJ-1 in Human Cerebrospinal Fluid
por: Kruse, Niels, et al.
Publicado: (2016)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
por: Emdina, Anna, et al.
Publicado: (2022)

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)
por: Chahine, Lana M., et al.
Publicado: (2018)

A Reliable Approach for Revealing Molecular Targets in Secondary Ion Mass Spectrometry
por: Li, Fengxia, et al.
Publicado: (2022)

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
por: Kruse, Niels, et al.
Publicado: (2018)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
por: Wislet-Gendebien, Sabine, et al.
Publicado: (2008)

NanoSIMS observations of mouse retinal cells reveal strict metabolic controls on nitrogen turnover
por: Bonnin, Elisa A., et al.
Publicado: (2021)

Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
por: Li, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7hfabvf64e5ibtvi7l3a41fvf8